Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs

OBJECTIVES: While cyclooxygenase-2 (COX-2) inhibitors were introduced to the U.S. market with the promise of less gastrointestinal (GI) toxicity than nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), additional research is needed to examine this outcome in the naturalistic setting. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockl, Karen, Cyprien, Lori, Chang, Eunice Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438022/
https://www.ncbi.nlm.nih.gov/pubmed/16137212
http://dx.doi.org/10.18553/jmcp.2005.11.7.550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438022/
https://www.ncbi.nlm.nih.gov/pubmed/16137212
http://dx.doi.org/10.18553/jmcp.2005.11.7.550

Ejemplares similares